Augustine Lawlor

CIK 1262327 · View on SEC EDGAR ↗

Insider

First SEC filing: March 18, 2026 · Latest: March 18, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 52 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

52 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Feb. 25, 2020 GYRE S 69,401 $6.10 $423,346 0 Indirect -100.00% Disposed -92.1% (price as of 2026-08-19)
Feb. 5, 2019 CYPH P 571,428 — — 592,797 Indirect +2674.10% Acquired (price as of 2026-08-19)
Feb. 5, 2019 CYPH P 571,428 $1.75 $999,999 4,114,804 Indirect +16.13% Acquired -95.1% (price as of 2026-08-19)
Nov. 14, 2017 CYPH P 1,057,769 — — 1,057,769 Indirect — Acquired (price as of 2026-08-19)
Nov. 14, 2017 CYPH P 1,057,769 $6.08 $6,431,236 3,573,376 Indirect +42.05% Acquired -98.6% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
March 28, 2025 CYPH Restricted Stock Units Common Stock (22,500) — — 22,500 Disposed
Nov. 13, 2024 CYPH Warrant (Right to Buy) Common Stock, $0.001 par value per share (2,136) $2.82 Nov. 14, 2024 2,136 Disposed
Oct. 2, 2024 CYPH Employee Stock Option (Right to Buy) Common Stock (85,000) $2.45 Oct. 2, 2034 85,000 Acquired
Jan. 29, 2024 CYPH Employee Stock Option (Right to Buy) Common Stock (85,000) $2.68 Jan. 29, 2034 85,000 Acquired
Jan. 26, 2024 CYPH Restricted Stock Units Common Stock (5,000) — — 5,000 Disposed
Aug. 23, 2023 CYPH Employee Stock Option (Right to Buy) Common Stock (70,000) $2.21 Aug. 23, 2033 70,000 Acquired
March 31, 2023 CYPH Employee Stock Option (Right to Buy) Common Stock (500,000) $0.34 March 31, 2033 500,000 Acquired
Sept. 1, 2022 CYPH Employee Stock Option (Right to Buy) Common Stock (200,000) $1.43 Aug. 31, 2032 200,000 Acquired
Jan. 31, 2022 CYPH Restricted Stock Units Common Stock (225,000) — — 225,000 Acquired
June 9, 2021 GYRE Stock Option (Right to Buy) Common Stock (14,000) $4.55 June 9, 2031 14,000 Acquired
May 26, 2021 CYPH Employee Stock Option (Right to Buy) Common Stock (30,000) $1.62 May 25, 2031 30,000 Acquired
Feb. 9, 2021 CYPH Warrant (Right to Buy) Common Stock, $0.001 par value per share (11,544) $1.95 Feb. 5, 2026 11,544 Acquired
Feb. 9, 2021 CYPH Warrant (Right to Buy) Common Stock, $0.001 par value per share (571,428) $1.95 Feb. 5, 2026 571,428 Disposed
Jan. 26, 2021 CYPH Restricted Stock Units Common Stock (50,000) — — 50,000 Acquired
Jan. 26, 2021 CYPH Employee Stock Option (Right to Buy) Common Stock (150,000) $2.57 Jan. 25, 2031 150,000 Acquired
Aug. 10, 2020 CYPH Stock Option (Right to Buy) Common Stock (75,000) $1.97 Aug. 9, 2030 75,000 Acquired
June 11, 2020 GYRE Stock Option (Right to Buy) Common Stock (5,000) $7.18 June 11, 2030 5,000 Acquired
April 9, 2020 CYPH Stock Option (Right to Buy) Common Stock (50,000) $1.69 April 9, 2030 50,000 Acquired
June 13, 2019 GYRE Stock Option (Right to Buy) Common Stock (5,000) $7.46 June 13, 2029 5,000 Acquired
June 11, 2019 CYPH Employee Stock Option (Right to Buy) Common Stock (200,000) $1.39 June 10, 2029 200,000 Acquired
Feb. 5, 2019 CYPH Warrant (Right to Buy) Common Stock, $0.001 par value per share (571,428) $1.95 Feb. 5, 2026 571,428 Acquired
Jan. 1, 2019 CYPH Employee Stock Option (Right to Buy) Common Stock (50,000) $2.00 Dec. 31, 2028 50,000 Acquired
July 30, 2018 CYPH Warrant (Right to Buy) Common Stock (21,369) $6.08 Nov. 14, 2024 21,369 Acquired
June 13, 2018 GYRE Stock Option (Right to Buy) Common Stock (5,000) $24.94 June 13, 2028 5,000 Acquired
April 18, 2018 CYPH Stock Option (Right to Buy) Common Stock, $0.001 par value per share $7.66 April 17, 2028 50,000 Acquired
Nov. 14, 2017 CYPH Warrant (Right to Buy) Common Stock, $0.001 par value per share (1,057,769) $6.08 Nov. 14, 2024 1,057,769 Acquired
July 13, 2017 GYRE Stock Option (Right to Buy) Common Stock (10,000) $4.40 July 13, 2027 10,000 Acquired
Jan. 23, 2017 CYPH Stock Option (Right to Buy) Common Stock, $0.001 par value per share $9.90 Jan. 22, 2027 330,303 Acquired
June 9, 2016 GYRE Stock Option (Right to Buy) Common Stock (7,500) $1.88 June 9, 2026 7,500 Acquired
Oct. 22, 2015 GYRE Stock Option (Right to Buy) Common Stock (6,750) $4.40 Oct. 22, 2025 6,750 Acquired
Oct. 22, 2015 GYRE Stock Option (Right to Buy) Common Stock (6,750) $4.40 Oct. 22, 2025 6,750 Acquired
Oct. 22, 2015 GYRE Stock Option (Right to Buy) Common Stock (8,250) $4.40 Oct. 22, 2025 8,250 Acquired
Aug. 20, 2015 GYRE Warrant (Right to Buy) Common Stock (14,056) $3.33 June 29, 2020 14,056 Acquired
Aug. 20, 2015 GYRE Warrant (Right to Buy) Common Stock (11,383) $3.33 May 29, 2020 11,383 Acquired
Aug. 20, 2015 GYRE Warrant (Right to Buy) Common Stock (2,254) $33.27 April 9, 2019 2,254 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
March 18, 2026 PRFX Employee Stock Option (Right to Buy) [F1]→ Ordinary Shares (50) 50 Direct
March 18, 2026 PRFX Employee Stock Option (Right to Buy) [F1]→ Ordinary Shares (183) 183 Direct
Jan. 23, 2017 CYPH Common Stock 5,477,902 Indirect

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CYPH

COO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2021 $436,667 — $128,500 $274,092 $209,600 — $47,567 $1,096,426
2020 $400,000 — — $141,841 $168,000 — $41,511 $751,352
2019 $400,000 — — $239,661 $140,000 — $36,207 $815,869

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.